Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Shapiro 5th Floor, Boston, MA, 02215, USA.
Int Ophthalmol. 2021 Sep;41(9):3021-3028. doi: 10.1007/s10792-021-01863-5. Epub 2021 Apr 24.
To examine how indications, patient characteristics, and outcomes differ between anterior and posterior approaches of endoscopic cyclophotocoagulation (ECP) in the treatment of glaucoma.
This is a retrospective chart review of 9 anterior and 20 posterior ECP cases (n = 29).
Posterior ECP cases were typically associated with a dramatic increase in intraocular pressure (IOP), whereas the anterior ECP was associated with chronically elevated pressures. The initial IOPs in mm Hg of posterior ECP cases (26.8 non-NVG; 35.2 NVG) were much greater than anterior ECP cases (17.8), and a greater overall reduction in IOP was observed in the posterior versus anterior ECP cases (10.3 posterior non-NVG; 21.3 posterior NVG; 3.6 anterior, P < .001). With procedural success defined as 6-month post-operative IOP falling within normal ranges and a decrease in either IOP or number of prescribed glaucoma medications, the success rate of ECP was 92% for posterior NVG, 89% for anterior and 75% for posterior non-NVG cases (P = .34), similar to the previous literature. Of the four unsuccessful cases, two resulted in a normal IOP but lacked a drop in pressure or reduction in medication burden, one resulted in a 6-point drop in IOP but remained at 23 mm Hg, and one resulted in phthisis bulbi (3%) from an initial pressure above 40 mm Hg.
Endoscopic cyclophotocoagulation is an effective and safe procedure for severe glaucoma cases from both an anterior and posterior approach. Ophthalmologists should consider this procedure as part of their glaucoma treatment arsenal.
探讨内镜睫状体光凝术(ECP)在前、后入路治疗青光眼时的适应证、患者特征和结局有何不同。
这是一项对 9 例前入路和 20 例后入路 ECP 病例(n=29)的回顾性图表分析。
后入路 ECP 病例通常与眼压(IOP)急剧升高有关,而前入路 ECP 则与慢性高眼压有关。后入路 ECP 病例的初始眼压(mmHg)明显高于前入路 ECP 病例(非新生血管性青光眼(NVG)26.8;NVG 35.2),后入路 ECP 病例的眼压总体下降幅度也大于前入路 ECP 病例(非 NVG 10.3;NVG 21.3;前入路 3.6,P<.001)。以术后 6 个月眼压降至正常范围且眼压或降眼压药物使用量减少为手术成功标准,后入路 NVG 的 ECP 成功率为 92%,前入路为 89%,后入路非 NVG 为 75%(P=.34),与既往文献相似。在 4 例手术失败的病例中,2 例眼压正常但未降低或减少药物使用负担,1 例眼压下降 6 个点但仍为 23mmHg,1 例初始眼压高于 40mmHg 导致眼球萎缩(3%)。
内镜睫状体光凝术从前、后入路治疗严重青光眼病例均安全有效。眼科医生应将该手术作为其青光眼治疗武器库的一部分。